These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. EBMT and ISHAGE-Europe create a foundation for inspection and accreditation in Europe. Kvalheim G; Berli M Cytotherapy; 1999; 1(5):363-4. PubMed ID: 20426536 [No Abstract] [Full Text] [Related]
4. US Food and Drug Administration regulatory oversight of laboratory-developed tests: Commentary on the draft guidance. Sidawy MK Cancer Cytopathol; 2015 Oct; 123(10):573-5. PubMed ID: 26042383 [No Abstract] [Full Text] [Related]
5. FDA Oversight of Laboratory-Developed Tests: Where Are We Now? Gatter K Arch Pathol Lab Med; 2017 Jun; 141(6):746-748. PubMed ID: 28557601 [No Abstract] [Full Text] [Related]
6. FDA's framework for regulatory oversight of LDTs. Pathak B; Terry SF Genet Test Mol Biomarkers; 2014 Dec; 18(12):785-6. PubMed ID: 25469801 [No Abstract] [Full Text] [Related]
7. How will the FDA impact the laboratory developed test? Davis J; Wentz J Clin Lab Sci; 2007; 20(3):130-1. PubMed ID: 17691668 [No Abstract] [Full Text] [Related]
8. United States Food and Drug Administration Regulation of Gene and Cell Therapies. Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210 [TBL] [Abstract][Full Text] [Related]
11. Role of the GMP facility for adoptive immunotherapy. McMannis JD; Champlin RE Cytotherapy; 2002; 4(4):329-31. PubMed ID: 12396832 [No Abstract] [Full Text] [Related]
12. [Recommendations of the American National Council for Clinical Laboratory Standardization (NCCLS)]. BalakhovskiÄ IS Klin Lab Diagn; 2002 Mar; (3):53-4. PubMed ID: 11980148 [No Abstract] [Full Text] [Related]
13. Nonculture tests for genital tract chlamydial infection: is the government the answer to our problems? de la Maza LM Sex Transm Dis; 1993; 20(6):352-5. PubMed ID: 8108761 [No Abstract] [Full Text] [Related]
14. Ensuring quality in genomic medicine: amid the rise in complex laboratory-developed tests, regulatory officials are seeking the right balance on quality assurance. Nelson B Cancer Cytopathol; 2014 Dec; 122(12):855-6. PubMed ID: 25510938 [No Abstract] [Full Text] [Related]
15. "Research use only" reagents: is there an imperative for increased FDA oversight? O'Leary TJ Clin Chem; 2011 Dec; 57(12):1681-3. PubMed ID: 21998341 [No Abstract] [Full Text] [Related]
16. Regulating laboratory-developed tests: devil will be in details. McNeil C J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25838442 [No Abstract] [Full Text] [Related]
17. Process validation. Preti RA Cytotherapy; 1999; 1(6):481-3. PubMed ID: 20426548 [TBL] [Abstract][Full Text] [Related]
18. Modification of In Vitro Diagnostic Devices: Leveling the Playing Field. Rychert J; Delgado JC; Genzen JR Clin Chem; 2020 Jun; 66(6):760-762. PubMed ID: 32278318 [No Abstract] [Full Text] [Related]
19. [Attempt to standardize clinical tests for the purpose of quality management in the field of clinical studies and clinical trials]. Ishibashi M; Komiyama Y; Furuta K Rinsho Byori; 2011 Oct; 59(10):978-87. PubMed ID: 22184881 [TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis of Ebola virus disease. Martin P; Laupland KB; Frost EH; Valiquette L Intensive Care Med; 2015 May; 41(5):895-8. PubMed ID: 25636586 [No Abstract] [Full Text] [Related] [Next] [New Search]